Midecamycin
- Level
- Commodity
- Parent
- 51284700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51284704This classification denotes a leucomycin and macrolides with the molecular formula C41H67NO15, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N34Z0Y5UH7, chemically known as leucomycin v, 3,4b-dipropanoate but generally known as midecamycin, which bears US NIH Compound Identifier 5382853. European Medicines Agency schedules midecamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08951MIG. The term MIDECAMYCIN is an International Non-Proprietary Name or INN. Most nations schedule midecamycin under HS 29419000 and SITC 54139. As of Q4 2014, MIDECAMYCIN remains the US FDA Preferred Term for this commodity. SMILES: CCC(=O)OC1CC(=O)OC(CC=CC=CC(C(CC(C(C1OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)O)C.
Same parent
Under 51284700 · 15Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.